The efficacy and safety of wedge resection for peripheral stage IA lung adenocarcinoma: a real-world study based on a single center

被引:3
|
作者
Bian, Dongliang [1 ]
Xiong, Yicheng [1 ]
Jin, Kaiqi [1 ]
Zhu, Yuming [1 ]
Yu, Huansha [2 ]
Dai, Jie [1 ]
Jiang, Gening [1 ]
机构
[1] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Thorac Surg, Shanghai, Peoples R China
[2] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Anim Expt Ctr, Shanghai, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Lung adenocarcinoma stage IA; wedge resection; recurrence; SECTION COMPUTED-TOMOGRAPHY; LIMITED RESECTION; SUBLOBAR RESECTION; SURVIVAL OUTCOMES; CANCER; LOBECTOMY; IMPACT; CLASSIFICATION;
D O I
10.21037/jtd-22-1010
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The effectiveness of segmentectomy for stage IA lung adenocarcinoma (IA-LUAD) has been well-documented. However, the efficacy and safety of wedge resection for peripheral IA-LUAD remains controversial. This study evaluated the feasibility of wedge resection in patients with peripheral IA-LUAD. Methods: Patients with peripheral IA- LUAD who underwent wedge resection by video- assisted thoracoscopic surgery (VATS) at Shanghai Pulmonary Hospital were reviewed. Cox proportional hazards modeling was performed to identify predictors of recurrence. Receiver operating characteristic (ROC) curve analysis was used to calculate the optimal cutoffs of identified predictors. Results: A total of 186 patients (female/male, 115/ 71; mean age, 59.9 years) were included. Mean maximum dimension of consolidation component (MCD) was 5.6 mm, consolidation-to-tumor ratio (CTR) was 37%, and mean computed tomography value of tumor (CTVt) was -285.4 HU. With a median follow-up of 67 months (interquartile range, 52-72 months), the 5-year recurrence rate was 4.84%. Ten patients occurred recurrence postoperatively. No recurrence was observed adjacent to the surgical margin. Increasing MCD, CTR, and CTVt were associated with a higher risk of recurrence, with corresponding hazard ratios (HRs) of 1.212 [95% confidence interval (CI): 1.120-1.311], 1.054 (95% CI: 1.018-1.092), and 1.012 (95% CI: 1.004-1.019) with optimal cutoffs for predicting recurrence of 10 mm, 60%, and -220 HU, respectively. When a tumor had characteristics under these respective cutoffs, no recurrence was observed. Conclusions: Wedge resection can be considered to be a safe and efficacious management strategy for patients with peripheral IA-LUAD, especially for MCD less than 10 mm, CTR less than 60% and CTVt less than -220 HU.
引用
收藏
页码:54 / 64
页数:11
相关论文
共 50 条
  • [31] Pretibial hematomas - A real-world single-center study
    Seppala, T.
    Grunthal, V.
    Koljonen, V.
    JPRAS OPEN, 2022, 32 : 79 - 87
  • [32] Efficacy and Safety of Fostamatinib in Elderly Patients with Immune Thrombocytopenia: A Single-Center, Real-World Case Series
    Liu, Jessica Chang
    Hsia, Cyrus C.
    BLOOD, 2022, 140 : 11265 - 11266
  • [33] Real-world efficacy and safety of capecitabine with oxaliplatin in patients with advanced adenocarcinoma of the ampulla of Vater
    Lee, Seunghwan
    Park, Se Jun
    Shin, Kabsoo
    Hong, Tae Ho
    Kim, In-Ho
    Lee, Myung Ah
    BMC CANCER, 2024, 24 (01)
  • [35] Success, Safety, and Efficacy of the Mynx Femoral Closure Device in a Real-World Cohort: Single-Center Experience
    Hutchings, David
    Hayat, Afzal
    Karunakaran, Arun
    Malik, Nadim
    JOURNAL OF INVASIVE CARDIOLOGY, 2016, 28 (03): : 104 - 108
  • [36] Safety And Efficacy of a Device to Narrow the Coronary Sinus for the Treatment of Refractory Angina: A Single Center 'Real-World' Experience
    Abawi, Masieh
    Stella, Pieter R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B59 - B59
  • [37] Efficacy and safety of sintilimab in combination with chemotherapy for recurrent extensive-stage small cell lung cancer: a real-world retrospective study
    Wang, Jingyi
    Liang, Shuzhi
    Xu, Li
    Kong, Yi
    Seki, Nobuhiko
    Ganti, Apar Kishor
    Neal, Joel W.
    Li, Jia
    Xu, Fang
    Li, Kang
    Xu, Yan
    Wu, Lin
    Chen, Bolin
    JOURNAL OF THORACIC DISEASE, 2024, 16 (06) : 3897 - 3908
  • [38] The clinical, radiological, postoperative pathological, and genetic features of nodular lung adenocarcinoma: a real-world single-center data
    Zhong, Weixiang
    Zhang, Wenshu
    Dai, Lei
    Chen, Mingwu
    JOURNAL OF THORACIC DISEASE, 2024, 16 (05) : 3228 - 3250
  • [39] Dissecting AI-based mutation prediction in lung adenocarcinoma: A comprehensive real-world study
    Dernbach, Gabriel
    Kazdal, Daniel
    Ruff, Lukas
    Alber, Maximilian
    Romanovsky, Eva
    Schallenberg, Simon
    Christopoulos, Petros
    Weis, Cleo-Aron
    Muley, Thomas
    Schneider, Marc A.
    Schirmacher, Peter
    Thomas, Michael
    Mueller, Klaus-Robert
    Budczies, Jan
    Stenzinger, Albrecht
    Klauschen, Frederick
    EUROPEAN JOURNAL OF CANCER, 2024, 211
  • [40] Real-world experience of the efficacy and safety of guselkumab 100 mg in patients with palmoplantar pustulosis in Korea: A retrospective single-center study
    Cho, Min Kyung
    Kim, Dong Hyun
    JAAD INTERNATIONAL, 2025, 18 : 117 - 118